PharmD, Universidad de Concepción

PhD in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona, 2014

• Research and dissemination of drug-drug interaction evidence.
• Health Technology Assessment through cost-effectiveness analysis.
• Economic impact of clinical pharmacist.
• Systematic reviews, meta-analysis and scoping review

2009-2014 Fulbright Scholarship for PhD study in the US

Professional Society for Health Economics and Outcomes Research (ISPOR)

International Society for Pharmacoepidemiology (ISPE)

Academy of Managed Care Pharmacy (AMCP)

My research interests are primarily focused on enhancing healthcare outcomes and optimizing the utilization of healthcare resources. Specific areas of interest include:

Pharmacoeconomics: Understanding the economic impact of drugs and pharmaceutical services, specifically evaluating the cost-effectiveness and value of drugs, technologies, and services provided by clinical pharmacists.

Drug-Drug Interaction: Investigating the nature and outcomes of drug-drug interactions, and disseminating this evidence to healthcare providers and the public to improve medication safety.

Health Technology Assessment: Evaluating the effectiveness, cost-effectiveness, and broader impact of health technologies and services.

Systematic Reviews and Meta-Analyses: Conducting comprehensive reviews and meta-analyses of existing literature to synthesize evidence on drug efficacy, safety, and cost-effectiveness, as well as the impact of clinical pharmacy services.

https://www.ncbi.nlm.nih.gov/myncbi/collections/mybibliography/